- Home
- FLEX vs DGX Comparison
FLEX vs DGX Comparison
Compare FLEX & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLEX | DGX |
|---|---|---|
| Founded | 1990 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.7B | 23.1B |
| IPO Year | 1997 | 1996 |
Fundamental Metrics
Financial Performance| Metric | FLEX | DGX |
|---|---|---|
| Price | $61.43 | $202.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | $60.00 | ★ $208.62 |
| AVG Volume (30 Days) | ★ 3.1M | 962.9K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 1.73% |
| EPS Growth | N/A | ★ 13.78 |
| EPS | 1.66 | ★ 8.75 |
| Revenue | ★ $28,679,925,000.00 | $11,035,000,000.00 |
| Revenue This Year | $8.09 | $7.55 |
| Revenue Next Year | $6.26 | $3.75 |
| P/E Ratio | $36.04 | ★ $22.81 |
| Revenue Growth | ★ 18.95 | 11.78 |
| 52 Week Low | $25.11 | $157.20 |
| 52 Week High | $72.22 | $213.50 |
Technical Indicators
Market Signals| Indicator | FLEX | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 43.77 | 51.11 |
| Support Level | $58.95 | $200.94 |
| Resistance Level | $66.93 | $213.35 |
| Average True Range (ATR) | 2.68 | 4.11 |
| MACD | -0.44 | -1.56 |
| Stochastic Oscillator | 21.79 | 29.39 |
Price Performance
Historical ComparisonAbout FLEX Flex Ltd.
Flex Ltd is a contract manufacturing company providing comprehensive electronics design, manufacturing, and product management services to electronics and technology companies. The company's operating segments include Flex Agility Solutions (FAS) and Flex Reliability Solutions (FRS). Flex Agility Solutions segment includes markets such as Communications, Enterprise and Cloud; Lifestyle; and Consumer Devices. Flex Reliability Solutions segment includes markets such as Automotive, Health Solutions, and Industrial.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.